Clinical Trial Update: Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating suvorexant for sleep disturbance in adults with chronic insomnia and suboptimally controlled type 2 diabetes; results h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Belsomra (suvorexant)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Type 2 Diabetes Mellitus, Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2023-03-02